🇺🇸 FDA
Patent

US 10111950

Modified glycolipids and methods of making and using the same

granted A61KA61K2039/505A61K2039/55572

Quick answer

US patent 10111950 (Modified glycolipids and methods of making and using the same) held by VACCINEX, INC. expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VACCINEX, INC.
Grant date
Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/505, A61K2039/55572, A61K2039/572, A61K2039/575